Objectives-To compare the outcome of occupational asthma (OA) induced by isocyanates in Ontario (where a surveillance programme for exposed workers has been in place for over 15 years), with the outcome of OA induced by other work agents.
Isocyanates are widely used in many parts of the world, especially in the manufacture of polyurethane foam and in spray paints. They have been reported to be the commonest cause of occupational asthma (OA) in Quebec,' Ontario,2 and Great Britain. 4 In a recent review by us of Ontario Workers' Compensation Board (WCB) claims for OA, exposure to isocyanates was identified in 30% of claims submitted and in 58% of claims accepted for OA.3
The outcome after removal from exposure has been relatively poor in OA induced by isocyanates.-10 By contrast with the report by Chan Yeung et al" of clearing of asthma symptoms in 84% of red cedar workers with OA after removal from exposure, clearing of asthma symptoms in those with OA induced by isocyanates has been reported in 0%-28% of subjects,5'-0 and 50% of subjects in one report.8
The report of Chan Yeung et al" in cedar workers and our report3 in a large group of claims compensated for OA from various causes have shown an association between early removal from exposure after diagnosis and better outcome of OA.
Unlike previous reports, our review of Follow up assessments were performed for disability decisions in subjects whose claims were accepted for occupational asthma and aggravation of asthma if respiratory impairment related to work was present at the initial assessment. The follow up assessment for disability rating was generally performed one to two years after the initial WCB decision, either by one of the three WCB physicians or a respiratory specialist selected by the WCB. This included a medical history, medication requirements, and pulmonary function testing. As with the initial assessment, there was no standardised format for the follow up assessment. Therefore, the outcome of asthma compared with the initial assessment was recorded for the purpose of this study as a global rating of asthma at that time, based on the assessing physician's letter. This was categorised relative to the initial data as cleared, improved, unchanged, or worsened asthma. The outcome was transcribed from the chart by the research assistant without knowledge of the intent to compare outcome of OA induced by isocyanates with that from other causes of OA. When the results of spirometry, methacholine, or histamine challenge results were available in the file, these were also included in the study data for later comparison with the global assessment rating.
Information was obtained from the Ontario Ministry of Labour as to whether or not the workplace of each patient with OA induced by isocyanates was recorded to be compliant with the isocyanate medical surveillance programme in the year during which OA had been diagnosed. Such information is recorded at the Ministry of Labour if a worksite visit has been made. This visit often results from a WCB or physician request in conjunction with a WCB claim, but could also occur at the request of workers or the company, or could be initiated by the Ministry of Labour when a company has been identified as using isocyanates. The duration of symptoms before diagnosis and the outcome of OA induced by isocyanates was compared for patients with and without known surveillance in the workplace.
STATISTICAL ANALYSIS
Statistical analysis was performed with the SAS package with GLM for analysis of variance, T TEST for Student's t tests, and FREQ for x2 analyses. Values are mean (SD). As information available in the files was not complete for all patients, missing data were excluded from calculations of percentages and from statistical analyses. Investigations showing an objective relation of asthma to the workplace were only available in 43% of accepted claims for OA induced by isocyanates. At the initial WCB assessment, only 20% were still at the same work, likely limiting further workplace pulmonary function investigations. Twenty two per cent already had clearing of symptoms by this assessment whereas 75% described continued limitation of activities by asthma symptoms. A methacholine or histamine challenge had been performed while working with isocyanates in 46 subjects (mean (SD) PC20 5.2 (11) mg/ml) and off work in 75 (mean PC20 11.2 (15) mg/ml). Among the 28 subjects who performed methacholine or histamine challenges both when working and away from work, the ratios were similar in the two groups ( Outcome for the 59 patients whose workplaces had surveillance measures in place was not significantly different from those without surveillance: 22% v 18% had clearing of asthma at follow up, whereas 51% v 55% had improved. However, worsening of asthma at follow up was recorded in 8% of those from plants with surveillance versus 18% of those without known surveillance.
Discussion
This study has an advantage over most previous studies of outcome of OA induced by isocyanates due to the presence of an internal comparison group of other Ontario WCB accepted claims for OA, and due to the relatively large numbers of patients relative to other studies. The number ofworkers on which previous studies have been based ranged from 12 to 50.5-10 The mean duration of exposure to isocyanates after the onset of symptoms of asthma in our study, 2.0 years (table 1), FEV, (% predicted) 113 (16) 104 (17) 101 (17) 80 (18) 0.001 FVC 117 (13) 108 (15) 107 (14) 97 (18 Footnotes as for table 1. compares with exposure means of 2.7 to 3.8 years in the other reports of outcome of OA induced by isocyanates in which symptoms cleared in 18%-28% of subjects (v 20% of those followed up in our study or 30% including those clear of asthma by the first assessment). In the study reported by Rosenberg et at in which asthmatic symptoms cleared in 50% of subjects with OA induced by isocyanates, the mean exposure after the onset of asthma symptoms was 1.2 years. However, criteria used for categorising outcome varied from study to study and therefore should be compared with caution. The diagnosis of OA was not objectively confirmed in all the WCB claims accepted for OA and some may have had coincidental asthma, perhaps accounting for a higher proportion of atopic asthmatic patients with this diagnosis compared with previous reports.59 Nevertheless, the outcome was not different in those with objective confirmation of the work relation compared with those without objective confirmation (data not shown). Also, those with coincidental asthma would not be expected to have an improvement in asthma after leaving work, and would not likely account for the overall better outcome in this study compared with several other reports.
The outcome is also better than in the group of other OA claims accepted by the Ontario WCB in the same period as this study, perhaps related to the shorter duration of symptoms before diagnosis and removal from exposure in the OA induced by isocyanates group (tables 1 and 3). The better outcome compared with other OA may also relate to the shorter latency of OA induced by isocyanates compared with other causes. A shorter latency of OA due to isocyanates compared with OA from high molecular weight allergens has been previously reported by Malo et al. " Chan Yeung et al have also reported that early development of OA with red cedar was associated with a better prognosis. " The shorter exposure time in our group with OA induced by isocyanates compared with other OA may reflect the value of the medical surveillance programme for isocyanate present in Ontario. This programme demands'3 that workplaces using these substances offer workers medical surveillance involving preplacement medical questionnaires including questions to detect asthmatic symptoms, as well as physical examination and spirometry. The questionnaire must be repeated at least every six months with spirometry if indicated at that time, or spirometry at least every two years. A 15% fall in forced expiratory volume in one second (FEVI) or vital capacity (VC) requires a referral for further medical assessment. Although specific information was not available at the Ontario Ministry of Labour for all plants that used isocyanates, about half of the cases of OA induced by isocyanates came from plants known to comply with this programme, and these accounted for the earlier mean diagnosis of OA induced by isocyanates compared with other causes of OA. It is not known whether the earlier diagnosis is due to the increased awareness by workers and healthcare providers of OA induced by isocyanates which is promoted by the existence of the programme or due to the questionnaire or spirometry. To our knowledge, this is the first study which suggests that a routine surveillance programme may have value in early detection of OA induced by isocyanates.
Continued exposure in the workplace, another variable which has been previously associated with a worse outcome,'4 15 was also associated with a worse outcome within our group of subjects with OA induced by isocyanates (tables 2 and 3) . However, the timing of the acute asthmatic response (early, late, or dual) was not a factor, unlike a report of subjects with red cedar OA;" nor was the degree of initial airflow limitation.3 "1 Also, we did not find a significant difference in outcome related to the type of isocyanate used or the type of occupational exposure.
Legislated allowable exposure limits in Ontario since 1983 for isocyanates have been a time weighted average not exceeding 0.005 ppm and a short term exposure limit of 0.02 ppm.13 Despite this legislation, isocyanates have remained the most common sensitiser in compensated claims for OA in Ontario. A recent assessment by us has suggested that the risk of OA induced by isocyanates is increased with higher measured environmental concentrations of isocyanates.'6 Further studies are needed to determine whether cases of OA arise from accidental short term breaches of allowable limits or whether longer term high exposures are occurring above recommended levels. It has been suggested that good engineering controls and low isocyanate concentrations can considerably reduce sensitisation.'5 The high proportion of OA due to isocyanates in this study emphasises the need for workers to follow appropriate safety procedures in the workplace, especially when exposure levels are likely to be increased (as in cleaning or maintaining equipment).
Our findings also emphasise the need for an early accurate diagnosis of OA induced by isocyanates with removal from exposure as soon as possible. Such an early diagnosis might be enhanced by medical surveillance programmes such as those which exist in Ontario. However, the value of such programmes in achieving this goal requires direct objective evaluation as has been suggested in a recent consensus statement on occupational asthma. '7 
